News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kemia, Inc. Closes Series C Financing


8/23/2006 11:05:55 AM

SAN DIEGO--(BUSINESS WIRE)--Aug. 23, 2006--Kemia announced today that it has closed its Series C financing, raising $31 million from new and existing investors. The company plans to use the proceeds to advance its lead clinical compound, KC706, through initial Phase II clinical trials and to progress additional Kemia programs into the clinic.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES